Efficacy of Repetitive Transcranial Magnetic Stimulation on Comorbid Anxiety and Depression Symptoms in Obsessive-Compulsive Disorder: A Meta-Analysis of Randomized Sham-Controlled Trials
The Canadian Journal of Psychiatry · 2023-06 · 68 (6) · 407-417
DOI: 10.1177/07067437221121112 ↗Kurz gefasst
Metaanalyse in der Zeitschrift The Canadian Journal of Psychiatry, online erschienen am 22.08.2022. Verfasst von Navya Spurthi Thatikonda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Obsessive-Compulsive Disorder Clinic, Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnatak…. Hauptthemen laut MEDLINE: Transcranial Magnetic Stimulation, Obsessive-Compulsive Disorder. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust.
Themen: Depression
Abstract (Originalsprache)
Objective
To systematically evaluate the efficacy of repetitive transcranial magnetic stimulation (rTMS) in reducing comorbid anxiety and depressive symptoms in patients with obsessive-compulsive disorder (OCD).
Methods
Three electronic databases were searched for randomized, sham-controlled clinical trials evaluating rTMS for the treatment of OCD. Hedge's g was calculated as the effect size for anxiety/depression symptom severity (primary outcome) and OCD severity (secondary outcome). Subgroup analyses and meta-regression analyses were carried out to evaluate the most promising target and whether a reduction in OCD severity moderates the change in anxiety or depression scores.
Results
Twenty studies ( n = 688) were included in the meta-analysis. rTMS had small-medium effect size on OCD (Hedge's g = 0.43; 95% confidence interval [CI]: [0.20, 0.65]; P < 0.001), anxiety (Hedge's g = 0.3; 95% CI: [0.11, 0.48]; P = 0.001) and depression (Hedge's g = 0.24; 95% CI: [0.07, 0.40]; P = 0.003) symptoms. Subgroup analysis showed that protocols targeting dorsolateral prefrontal cortex (DLPFC) were effective for 3 outcome measures. The change in anxiety, but not depression severity, was moderated by a change in OCD symptom scores. However, the findings are uncertain as a majority of the studies had some concerns or a high risk of bias.
Conclusions
Active rTMS protocol targeting DLPFC is effective in reducing the comorbid anxiety/depression symptoms along with OCD severity. The antidepressant effect is not moderated by the anti-obsessive effect of rTMS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Obsessive-Compulsive Disorder Clinic, Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
- Department of Biostatistics, NIMHANS, Bengaluru, Karnataka, India.
ORCID-Profile: Navya Spurthi Thatikonda, Pratibha Vinod, Srinivas Balachander, Y C Janardhan Reddy
Förderung
- Wellcome Trust
Zitieren
APA
Thatikonda, N. S., Vinod, P., Balachander, S., Bhaskarpillai, B., Arumugham, S. S., & Reddy, Y. C. J. (2023). Efficacy of Repetitive Transcranial Magnetic Stimulation on Comorbid Anxiety and Depression Symptoms in Obsessive-Compulsive Disorder: A Meta-Analysis of Randomized Sham-Controlled Trials. The Canadian Journal of Psychiatry, 68(6), 407-417. https://doi.org/10.1177/07067437221121112
Vancouver
Thatikonda NS, Vinod P, Balachander S, Bhaskarpillai B, Arumugham SS, Reddy YCJ. Efficacy of Repetitive Transcranial Magnetic Stimulation on Comorbid Anxiety and Depression Symptoms in Obsessive-Compulsive Disorder: A Meta-Analysis of Randomized Sham-Controlled Trials. The Canadian Journal of Psychiatry. 2023;68(6):407-417. doi:10.1177/07067437221121112
BibTeX
@article{Thatikonda2023,
author = {Thatikonda, Navya Spurthi and Vinod, Pratibha and Balachander, Srinivas and Bhaskarpillai, Binukumar and Arumugham, Shyam Sundar and Reddy, Y C Janardhan},
title = {Efficacy of Repetitive Transcranial Magnetic Stimulation on Comorbid Anxiety and Depression Symptoms in Obsessive-Compulsive Disorder: A Meta-Analysis of Randomized Sham-Controlled Trials},
journal = {The Canadian Journal of Psychiatry},
year = {2023},
volume = {68},
number = {6},
pages = {407--417},
doi = {10.1177/07067437221121112}
}
EUVIMED